ArticleJournal of the advanced practitioner in oncology2021

An Evaluation of the Use of Corticosteroids for the Management of Immune-Mediated Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors.

Adrian Tsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.